Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria de Navarra (10)

2022

  1. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

    Cancer Letters, Vol. 529, pp. 70-84

  2. DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity

    The Journal of experimental medicine, Vol. 219, Núm. 12

2021

  1. Paradigms on immunotherapy combinations with chemotherapy

    Cancer Discovery, Vol. 11, Núm. 6, pp. 1353-1367

2020

  1. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

  2. Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

    Nature cancer, Vol. 1, Núm. 1, pp. 75-85

2019

  1. The dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patients

    Disease Markers, Vol. 2019

2018

  1. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma

    Lung Cancer, Vol. 122, pp. 120-123

2016

  1. Bringing model-based prediction to oncology clinical practice: A review of Pharmacometrics principles and applications

    Oncologist, Vol. 21, Núm. 2, pp. 220-232

  2. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

    Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694

2015

  1. Early prediction of disease progression in small cell lung cancer: Toward model-based personalized medicine in oncology

    Cancer Research, Vol. 75, Núm. 12, pp. 2416-2425